Bio-Rad to Present at Jefferies 2018 Global Healthcare Conference on June 5

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, and Christine Tsingos, Executive Vice President and CFO, will present at the Jefferies 2018 Global Healthcare Conference on Tuesday, June 5, at 10 AM (EST), in New York, NY.

A link to the live webcast of the presentation is available in the Investor Relations area of our website at www.bio-rad.com.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,000 employees worldwide. Bio-Rad had revenues exceeding $2.1 billion in 2017. For more information, please visit www.bio-rad.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180530006571/en/

Bio-Rad Laboratories, Inc.
Tina Cuccia, 510-724-7000
Corporate Communications
[email protected]

Source: Bio-Rad Laboratories, Inc.

You May Also Be Interested In

• RIWI Releases Q2 2026 Financials
• Granite Asia Ranked No. 1 Top Private Equity Firm in Asia Among Singapore’s Leading Financial Firms, Independent Research Finds
• APEX Anesthesia Review Launches Dedicated CRNA Job Board to Connect Employers with the Nation's Most Engaged Nurse Anesthesia Community